BGP-15

N/A

Report date: 2025/03/12 14:03:00
NME

Base Information

Drug NameBGP-15
Drug Alias NameBGP-15
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitorsHSP70 heat-shock proteins stimulantsc-Jun N-terminal kinase inhibitors +[4] 
TargetsPoly (ADP-Ribose) polymeraseHSP70 heat-shock proteinsc-Jun N-terminal kinase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHungaryGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN-Gene Research Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN-Gene Research Laboratories Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A